DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

We're going to check out a few of the best picks from our screener tool. Overview: Bitdeer Technologies Group is a technology company focused on blockchain and computing, with a market cap of $1.67 ...

Dominic Walsh, a business reporter who previously covered the leisure and drinks industry for The Times from 1997 to 2024, stated in post to X: ...

Mamtani covers the Healthcare sector, focusing on stocks such as Cytokinetics, Novavax, and TG Therapeutics. According to TipRanks, Mamtani has an average return of -10.8% and a 28.60% success rate on ...

Over the last 7 days, the United States market has risen by 5.7%, contributing to a remarkable increase of 37% over the past year, with earnings anticipated to grow by 16% annually in the coming years ...

NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the third quarter of 2024, along with recent ...

As global markets react to the recent U.S. election results, with major indices like the small-cap Russell 2000 seeing significant gains, investor optimism is fueled by expectations of growth-friendly ...

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q2 2025 Earnings Call Transcript November 10, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the Vistagen Therapeutics Fiscal Year 2025 ...

TG Therapeutics (NASDAQ:TGTX – Free Report) had its target price increased by HC Wainwright from $49.00 to $55.00 in a report ...

On Friday, TG Therapeutics Inc common stock (TGTX) stock saw a modest uptick, ending the day at $28.81 which represents a slight increase of $0.91 or 3.26% from the prior close of $27.9. The stock ...

Over the last 7 days, the United States market has risen by 5.1%, contributing to an impressive 38% increase over the past year, with earnings forecasted to grow by 15% annually. In this context of ...

It's been a good week for TG Therapeutics, Inc. ( NASDAQ:TGTX ) shareholders, because the company has just released ...